Paul Tudor Jones Tudor Investment Corp
Paul Tudor Jones is the founder of Tudor Investment Corporation and a pioneering macro trader. He rose to prominence after navigating the 1987 market crash successfully and has since built a multi-strategy firm spanning global markets. Jones is widely associated with discretionary macro trading, risk management discipline, and high-profile philanthropic efforts in education and the environment.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$53.9M |
| 2 |
COUP
Coupa Software Incorporated
COUP
|
+$32.1M |
| 3 |
COWN
Cowen Inc. Class A Common Stock
COWN
|
+$27.8M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$20.1M |
| 5 |
M&T Bank
MTB
|
+$20.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Y
Alleghany Corp
Y
|
+$93.4M |
| 2 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$71.8M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$42.9M |
| 4 |
ZEN
ZENDESK INC
ZEN
|
+$42.3M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$41.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.01% |
| 2 | Financials | 11.75% |
| 3 | Industrials | 10.85% |
| 4 | Healthcare | 10.32% |
| 5 | Consumer Discretionary | 8.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Teva Pharmaceuticals
TEVA
$43.5B
| $10.5M | 0.21% |
1,146,119
+21,032
| +2% | +$184K |
|
77
Parker-Hannifin
PH
$126B
| $10.4M | 0.21% |
35,762
-6,604
| -16% | -$1.89M |
|
78
Capri Holdings
CPRI
$1.55B
| $10.4M | 0.2% |
180,676
+172,919
| +2,229% | +$8.74M |
|
|
SGI
79
Somnigroup International
SGI
$13.6B
| $10.1M | 0.2% |
294,376
+236,868
| +412% | +$7.13M |
|
|
AJRD
80
DELISTED
Aerojet Rocketdyne Holdings
AJRD
| $10.1M | 0.2% |
+180,000
| New | +$8.91M |
|
81
Paylocity
PCTY
$8.14B
| $10.1M | 0.2% |
+51,794
| New | +$11.1M |
|
82
Otis Worldwide
OTIS
$27.2B
| $9.98M | 0.2% |
127,499
| – | – |
|
83
Public Storage
PSA
$60.2B
| $9.98M | 0.2% |
35,624
+24,662
| +225% | +$7.19M |
|
84
PUT
lululemon athletica
LULU
$13.7B
| $9.93M | 0.2% |
+31,000
| New | +$10.2M |
|
85
PUT
DuPont de Nemours
DD
$18.7B
| $9.92M | 0.2% |
115,118
+96,795
| +528% | +$7.73M |
|
86
PJT Partners
PJT
$4.47B
| $9.88M | 0.2% |
134,012
-43,000
| -24% | -$3.22M |
|
87
Linde
LIN
$225B
| $9.76M | 0.19% |
+29,913
| New | +$9.38M |
|
|
CNH
88
CNH Industrial
CNH
$19.1B
| $9.74M | 0.19% |
606,710
+268,946
| +80% | +$3.87M |
|
|
ATVI
89
DELISTED
Activision Blizzard
ATVI
| $9.69M | 0.19% |
126,518
+49,861
| +65% | +$3.7M |
|
|
SWIR
90
DELISTED
Sierra Wireless
SWIR
| $9.6M | 0.19% |
331,239
-7,823
| -2% | -$230K |
|
91
Intercontinental Exchange
ICE
$90.5B
| $9.59M | 0.19% |
93,504
+86,993
| +1,336% | +$8.66M |
|
|
ATVI
92
CALL
DELISTED
Activision Blizzard
ATVI
| $9.57M | 0.19% |
+125,000
| New | +$9.28M |
|
93
CALL
Warner Bros
WBD
$71.6B
| $9.55M | 0.19% |
1,007,900
+972,300
| +2,731% | +$11M |
|
|
CFLT
94
DELISTED
Confluent
CFLT
| $9.52M | 0.19% |
427,978
+33,805
| +9% | +$783K |
|
|
BLD
95
DELISTED
TopBuild
BLD
| $9.38M | 0.19% |
59,966
+53,967
| +900% | +$8.59M |
|
96
CALL
ARK Innovation ETF
ARKK
$6.72B
| $9.37M | 0.19% |
+300,000
| New | +$10.7M |
|
97
S&P Global
SPGI
$127B
| $9.33M | 0.18% |
27,849
-39,290
| -59% | -$13M |
|
98
Williams-Sonoma
WSM
$28B
| $9.29M | 0.18% |
161,688
+88,186
| +120% | +$5.29M |
|
99
Labcorp
LH
$27.3B
| $9.29M | 0.18% |
45,904
+39,918
| +667% | +$7.8M |
|
100
CubeSmart
CUBE
$9.21B
| $9.28M | 0.18% |
230,454
+143,788
| +166% | +$5.79M |
|
Similar funds
Paul Tudor Jones's Q4 2022 Portfolio in Review
As of Q4 2022, Paul Tudor Jones held 3,056 positions worth $5.06B, up 9.2% from $4.63B the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.
Paul Tudor Jones deployed $198M of net new capital in Q4 2022, opening 801 new positions and adding to 766 existing holdings. Its largest new stake was Horizon Therapeutics Public Limited Company Ordinary Shares: 648,672 shares worth $73.8M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was iShares MSCI Emerging Markets ETF, an estimated $39M trimmed.
- Paul Tudor Jones's largest Q4 2022 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 648,672 shares worth $73.8M.
- Paul Tudor Jones added most to Coupa Software Incorporated in Q4 2022, an estimated $32.1M increase.
- Paul Tudor Jones's biggest Q4 2022 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $39M.
- Paul Tudor Jones fully exited Alleghany Corp in Q4 2022, selling an estimated $93.4M.
- Paul Tudor Jones's ten largest holdings make up 9.1% of its $5.06B portfolio in Q4 2022.
- Paul Tudor Jones opened 801 new positions and closed 756 in Q4 2022.
- Paul Tudor Jones's portfolio value rose 9.2% quarter-over-quarter to $5.06B.
Based on Tudor Investment Corp's 13F filing for Q4 2022, filed 14 Feb 2023.